Mulmit

Bolt Biotherapeutics, Inc.Bolt Biotherapeutics, Inc.

BOLT Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-317,695,000-36,113,000-33,376,000-17.85
2024-12-317,690,000-73,048,000-63,118,000-33.06
2023-12-317,876,000-76,196,000-69,197,000-1.83
2022-12-315,729,000-90,321,000-88,098,000-2.36
2021-12-311,260,000-92,788,000-98,591,000-2.97

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-10Berner Laura5,000
2026-06-10LAPORTE KATHLEEN5,000
2026-06-10Dupont Jakob5,000
2026-06-10O'CALLAGHAN BRIAN5,000
2026-06-10ONETTO NICOLE5,000
2026-01-28Quinn William P.President, CEO and CFO20,000
2026-01-28Yonehiro GrantChief Operating Officer10,000
2026-01-28Nemec SarahSenior VP, Finance and PAO8,000
2025-12-12Dupont Jakob2,500
2025-12-12Dupont Jakob2,500
2025-12-12Dupont Jakob849
2025-12-12Dupont Jakob849

8-K events

FiledItems
2026-08-11Results of operations · Financial statements and exhibits
2026-06-11Submission of matters to a vote
2026-05-12Results of operations · Financial statements and exhibits
2026-03-12Results of operations · Financial statements and exhibits
2025-11-12Results of operations · Financial statements and exhibits
2025-10-02Costs associated with exit or disposal activities · Other events
2025-08-14Results of operations · Financial statements and exhibits
2025-06-06Delisting or listing-standard notice · Amendments to charter or bylaws
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.